Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 1
1988 3
1989 1
1990 3
1992 4
1993 4
1994 3
1996 2
1997 7
1998 7
1999 5
2000 1
2001 8
2002 4
2003 11
2004 8
2005 6
2006 3
2007 6
2008 11
2009 6
2010 8
2011 7
2012 9
2013 4
2014 6
2015 8
2016 10
2017 9
2018 8
2019 12
2020 10
2021 8
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

195 results
Results by year
Filters applied: . Clear all
Page 1
The collaborative ocular melanoma study.
Singh AD, Kivelä T. Singh AD, et al. Ophthalmol Clin North Am. 2005 Mar;18(1):129-42, ix. doi: 10.1016/j.ohc.2004.11.004. Ophthalmol Clin North Am. 2005. PMID: 15763198 Review.
This review provides a summary of the main objectives, significant design features, and major findings and achievements of the Collaborative Ocular Melanoma Study (COMS). It has been written by two ophthalmic oncologists who were not part of the COMS …
This review provides a summary of the main objectives, significant design features, and major findings and achievements of the Collaborat
The Collaborative Ocular Melanoma Study: an overview.
Margo CE. Margo CE. Cancer Control. 2004 Sep-Oct;11(5):304-9. doi: 10.1177/107327480401100504. Cancer Control. 2004. PMID: 15377989 Free article. Review.
BACKGROUND: The Collaborative Ocular Melanoma Study (COMS) is a 3-arm study that includes two multicenter randomized clinical trials designed to compare the effectiveness of brachytherapy to enucleation for treatment of medium-size choroidal …
BACKGROUND: The Collaborative Ocular Melanoma Study (COMS) is a 3-arm study that includes two multicenter …
Clinical outcomes of Modified Collaborative Ocular Melanoma Study IRIS plaques for treatment of iris, iridociliary, and ciliary body melanoma.
Xu TT, Pulido JS, Deufel CL, Corbin KS, Petersen IA, Dalvin LA. Xu TT, et al. Eye (Lond). 2021 Oct;35(10):2754-2762. doi: 10.1038/s41433-020-01295-y. Epub 2020 Nov 24. Eye (Lond). 2021. PMID: 33235338
BACKGROUND/OBJECTIVES: To report clinical outcomes of modified Collaborative Ocular Melanoma Study IRIS (COMS IRIS) plaques for treatment of iris, iridociliary, and ciliary body melanoma. SUBJECTS/METHODS: Retrospective, single-centre cohort …
BACKGROUND/OBJECTIVES: To report clinical outcomes of modified Collaborative Ocular Melanoma Study IRIS (COMS IR …
EyeDose: An open-source tool for using published Monte Carlo results to estimate the radiation dose delivered to the tumor and critical ocular structures for 125I Collaborative Ocular Melanoma Study eye plaques.
Deufel CL, McCauley Cutsinger S, Corbin KS, Dalvin LA, Petersen IA. Deufel CL, et al. Brachytherapy. 2021 Jan-Feb;20(1):189-199. doi: 10.1016/j.brachy.2020.09.007. Epub 2020 Nov 10. Brachytherapy. 2021. PMID: 33187821
We have developed an open-source software tool, EyeDose, to simplify and standardize tumor and critical structure dose reporting for Collaborative Ocular Melanoma Study eye plaques. METHODS AND MATERIALS: EyeDose is a MATLAB-based program that calculat …
We have developed an open-source software tool, EyeDose, to simplify and standardize tumor and critical structure dose reporting for Coll
Optic Disc Dose Comparison Between 125I and 103Pd Collaborative Ocular Melanoma Study (COMS) Plaques Based on Current Clinical Practice.
Lee YC, Lin SC, Kim Y. Lee YC, et al. Cureus. 2021 Jun 28;13(6):e15980. doi: 10.7759/cureus.15980. eCollection 2021 Jun. Cureus. 2021. PMID: 34336471 Free PMC article.
Purpose The purpose of this study is to compare optic disc dose (ODD) between (125)I and (103)Pd Collaborative Ocular Melanoma Study (COMS) plaques in ocular brachytherapy. ...For small BDs, at DT <d(t), ODD for (103)Pd COMS plaques is …
Purpose The purpose of this study is to compare optic disc dose (ODD) between (125)I and (103)Pd Collaborative Ocular
Collaborative ocular melanoma study randomized trial of I-125 brachytherapy.
Hawkins BS. Hawkins BS. Clin Trials. 2011 Oct;8(5):661-73. doi: 10.1177/1740774511419684. Clin Trials. 2011. PMID: 22013172 Clinical Trial.
PURPOSE: The Collaborative Ocular Melanoma Study (COMS) was designed to compare enucleation and radiotherapy among similar patients with respect to survival outcomes. ...CONCLUSIONS: The multidisciplinary COMS Group not only successfully conducted a ra …
PURPOSE: The Collaborative Ocular Melanoma Study (COMS) was designed to compare enucleation and radiotherapy amo …
Collaborative ocular melanoma study group.
Fine SL. Fine SL. Arch Fam Med. 1999 Jan-Feb;8(1):11-2. doi: 10.1001/archfami.8.1.11-a. Arch Fam Med. 1999. PMID: 9932065 No abstract available.
Dosimetric comparison of circular Eye Physics and Collaborative Ocular Melanoma Study plaques to treat uveal melanoma.
Dean MK, Studenski MT, Paez-Escamilla MA, Walter SD, Kwon D, Markoe AM, Harbour JW, Samuels SE. Dean MK, et al. Brachytherapy. 2019 May-Jun;18(3):404-410. doi: 10.1016/j.brachy.2019.01.005. Epub 2019 Feb 20. Brachytherapy. 2019. PMID: 30797699
PURPOSE: We sought to formally compare Collaborative Ocular Melanoma Study (COMS) and similar-shaped (circular) eye physics (EP) plaques dosimetrically by examining both tumor coverage and critical structure doses. METHODS AND MATERIALS: The plans of p …
PURPOSE: We sought to formally compare Collaborative Ocular Melanoma Study (COMS) and similar-shaped (circular) …
195 results